450 related articles for article (PubMed ID: 17389666)
1. Use of atypical antipsychotics in the treatment of autistic disorder.
Stachnik JM; Nunn-Thompson C
Ann Pharmacother; 2007 Apr; 41(4):626-34. PubMed ID: 17389666
[TBL] [Abstract][Full Text] [Related]
2. Off-label second generation antipsychotics for impulse regulation disorders: a review.
Scheltema Beduin A; de Haan L
Psychopharmacol Bull; 2010; 43(3):45-81. PubMed ID: 21150846
[TBL] [Abstract][Full Text] [Related]
3. Treatments for late-life bipolar disorder.
Aziz R; Lorberg B; Tampi RR
Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
[TBL] [Abstract][Full Text] [Related]
4. Tolerability of atypical antipsychotics in the treatment of adults with schizophrenia or bipolar disorder: a mixed treatment comparison of randomized controlled trials.
Edwards SJ; Smith CJ
Clin Ther; 2009 Jun; 31 Pt 1():1345-59. PubMed ID: 19698898
[TBL] [Abstract][Full Text] [Related]
5. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
Baghdadli A; Gonnier V; Aussilloux C
Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
[TBL] [Abstract][Full Text] [Related]
6. Role of risperidone in children with autism spectrum disorder.
Chavez B; Chavez-Brown M; Rey JA
Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811
[TBL] [Abstract][Full Text] [Related]
7. Management of atypical antipsychotic drug-induced weight gain: focus on metformin.
Miller LJ
Pharmacotherapy; 2009 Jun; 29(6):725-35. PubMed ID: 19476423
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of naltrexone use in pediatric patients with autistic disorder.
Elchaar GM; Maisch NM; Augusto LM; Wehring HJ
Ann Pharmacother; 2006 Jun; 40(6):1086-95. PubMed ID: 16735648
[TBL] [Abstract][Full Text] [Related]
9. Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: a review of the randomized controlled studies.
Zuddas A; Zanni R; Usala T
Eur Neuropsychopharmacol; 2011 Aug; 21(8):600-20. PubMed ID: 21550212
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of atypical antipsychotics in mood disorders.
Yatham LN
J Clin Psychopharmacol; 2003 Jun; 23(3 Suppl 1):S9-14. PubMed ID: 12832944
[TBL] [Abstract][Full Text] [Related]
11. Emerging treatments for bipolar disorder: safety and adverse effect profiles.
Marken PA; Pies RW
Ann Pharmacother; 2006 Feb; 40(2):276-85. PubMed ID: 16403851
[TBL] [Abstract][Full Text] [Related]
12. Clinical utilization of atypical antipsychotics in pregnancy and lactation.
Gentile S
Ann Pharmacother; 2004; 38(7-8):1265-71. PubMed ID: 15150376
[TBL] [Abstract][Full Text] [Related]
13. Advances in pharmacotherapy of psychotic disorders in the elderly.
Kirkwood CK; Givone DM
Consult Pharm; 2003 Jun; 18(6):539-50. PubMed ID: 16563063
[TBL] [Abstract][Full Text] [Related]
14. Augmentation with atypical antipsychotics for depression: a review of evidence-based support from the medical literature.
Wright BM; Eiland EH; Lorenz R
Pharmacotherapy; 2013 Mar; 33(3):344-59. PubMed ID: 23456734
[TBL] [Abstract][Full Text] [Related]
15. Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders.
McDougle CJ; Stigler KA; Erickson CA; Posey DJ
J Clin Psychiatry; 2008; 69 Suppl 4():15-20. PubMed ID: 18533764
[TBL] [Abstract][Full Text] [Related]
16. Atypical antipsychotics versus haloperidol for treatment of delirium in acutely ill patients.
Rea RS; Battistone S; Fong JJ; Devlin JW
Pharmacotherapy; 2007 Apr; 27(4):588-94. PubMed ID: 17381385
[TBL] [Abstract][Full Text] [Related]
17. Mood stabilizers and atypical antipsychotics: bimodal treatments for bipolar disorder.
Ketter TA; Nasrallah HA; Fagiolini A
Psychopharmacol Bull; 2006; 39(1):120-46. PubMed ID: 17065977
[TBL] [Abstract][Full Text] [Related]
18. Use of antipsychotics in children and adolescents.
Findling RL; Steiner H; Weller EB
J Clin Psychiatry; 2005; 66 Suppl 7():29-40. PubMed ID: 16124839
[TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapy of behavioral and psychological symptoms of dementia: a review of atypical antipsychotics.
Daiello LA; Beier MT; Hoffmann VP; Kennedy JS
Consult Pharm; 2003 Feb; 18(2):138-52, 155-7. PubMed ID: 16563055
[TBL] [Abstract][Full Text] [Related]
20. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
